Dopamine Beta-Hydroxylase Deficiency

Also known as: Dopamine beta-hydroxylase deficiency

DrugDrug NameDrug Description
DB06262DroxidopaA medication used to treat symptomatic neurogenic orthostatic hypotension (nOH) caused by dopamine beta-hydroxylase deficiency, non-diabetic autonomic neuropathy and primary autonomic failure caused by conditions such as Parkinson's disease.
DrugDrug NamePhaseStatusCount
DB00572Atropine1Active Not Recruiting1
DB00575Clonidine1Active Not Recruiting1
DB01010Edrophonium1Active Not Recruiting1
DB01064Isoprenaline1Active Not Recruiting1
DB00968Methyldopa1Active Not Recruiting1
DB01233Metoclopramide1Active Not Recruiting1
DB00325Nitroprusside1Active Not Recruiting1
DB00388Phenylephrine1Active Not Recruiting1
DB00571Propranolol1Active Not Recruiting1
DB08841Tyramine1Active Not Recruiting1
DB01392Yohimbine1Active Not Recruiting1
DB00289Atomoxetine3Enrolling by Invitation1
DB00190Carbidopa3Enrolling by Invitation1
DB06262Droxidopa3Enrolling by Invitation1
DB01235Levodopa3Enrolling by Invitation1
DB00968Methyldopa3Enrolling by Invitation1
DB01233Metoclopramide3Enrolling by Invitation1
DB00765Metyrosine3Enrolling by Invitation1